Resources & Evidence Contact us

143 Results:

Sort By:

Prolacta Bioscience applauds passage of New York legislation expanding insurance coverage for human milk-based nutritional products

Type: Press Releases

Topic(s): Advocacy Company

Prolacta Bioscience applauds new California state law expanding access to donor human milk for fragile infants

Type: Press Releases

Topic(s): Company Necrotizing Entercolitis (NEC)

More than 50% of level III & IV NICUs in U.S. used Prolacta's 100% human milk-based products to help reduce Necrotizing Enterocolitis (NEC) in the smallest premature infants in 2024

Type: Press Releases

Topic(s): Company Necrotizing Entercolitis (NEC)

Prolacta Bioscience applauds passage of the maternal health bill in Massachusetts

Type: Press Releases

Topic(s): Advocacy

Working to address equity in premature nutrition, National Black Nurses Association and Prolacta Bioscience support H.R. 7141

Type: Press Releases

Topic(s): Cost Savings / Cost Effectiveness Early Fortification Growth Product

Preterm infant study finds proactive use of Prolact CR cream improves growth and reduces NICU costs

Type: Press Releases

Topic(s): Cost Savings / Cost Effectiveness Early Fortification Growth Product

Prolacta Bioscience demonstrates leadership in human milk science with history of voluntarily reviewing health claims with the FDA

Type: Press Releases

Topic(s): Company

Human milk-based fortifiers cut mortality rate by 50% in preterm infants, independent study shows

Type: Press Releases

Topic(s): Clinical Studies Mortality

Study shows exclusive human milk diet benefits term infants post-gastroschisis repair; Data to be presented at ESPGHAN 2024 meeting

Type: Press Releases

Topic(s): Clinical Studies Conferences and Events

Not finding the reference you’re looking for?

Use our main search field or email us at info@prolacta.com